Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Prostate Cancer treatment details. Chemotherapy. University of Athens School of Medicine, Athens, Greece

Survival: 18.8 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Emcyt
Country: Greece
City/State/Province: Athens
Hospital: University of Athens School of Medicine
Journal: Link
Date: 1/2004

Patients: This Phase II study involved 38 patients with hormone refractory prostate cancer. Patients were divided into two groups: Group 1 and Group 2. The average age of patients in Group 1 was 73 years and the median PSA was 56 (range from .1 823).

Treatment: The patients in Group 1 were treated with chemotherapy estramustine (emcyt) and etoposide (VP16, vepesid).

Toxicity: For patients in Group 1, grade 3-4 toxicities included neutropenia, anemia, thrombocytopenia, and alopecia.

Results: The median overall survival for patients in Group 1 was 18.8 months.

Correspondence: M.A. Dimopoulos, MD

E-mail to a Friend More Information